quinuclidines has been researched along with prazosin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitamura, Y; Nomura, Y; Ohnuki, T; Zhao, XH | 1 |
| Imai, S; Nagatomo, T; Tsuchihashi, H | 1 |
| Kagan, OF; Kheĭfets, VKh; Sosnovskiĭ, SO | 2 |
1 trial(s) available for quinuclidines and prazosin
| Article | Year |
|---|---|
[Peculiarities of clinical course, diagnostics and treatment of overactive bladder in men older than 60 years].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Prostatitis; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents | 2014 |
3 other study(ies) available for quinuclidines and prazosin
| Article | Year |
|---|---|
Ligand-binding characteristics of [3H]QNB, [3H]prazosin, [3H]rauwolscine, [3H]TCP and [3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse.
Topics: Aging; Animals; Cerebral Cortex; Hippocampus; Male; Mice; Prazosin; Quinuclidines; Quinuclidinyl Benzilate; Receptors, Adrenergic, alpha; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1989 |
Effects of deoxyribonuclease I and neuraminidase treatments on the specific binding of 3H-prazosin and 3H-quinuclidinyl benzilate (3H-QNB) to alpha-adrenergic and muscarinic receptors in rat myocardial membranes.
Topics: Animals; Cell Membrane; Deoxyribonuclease I; Kinetics; Male; Myocardium; Neuraminidase; Prazosin; Quinuclidines; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Muscarinic; Tritium | 1986 |
[ASSESSMENT OF EFFICIENCY OF TREATMENT OF OVERACTIVE BLADDER IN ELDERLY PATIENTS].
Topics: Adrenergic alpha-1 Receptor Antagonists; Age Factors; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Prazosin; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2015 |